Trial
NCT04822298
Study of AMG 160 in Subjects With Non-Small Cell Lung Cancer
Phase ITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Amgen
Collaborators
—
Condition
Non-small Cell Lung Cancer
Intervention
AMG 160
Why stopped
Amgen made a business decision to discontinue AMG 160 20180273
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2024-07-05